TCBP logo

TC Biopharm (Holdings) (TCBP) Company Overview

Profile

Full Name:

TC Biopharm (Holdings) Plc

Sector:

Healthcare

Industry:

Biotechnology

Country:

United Kingdom

IPO:

February 11, 2022

Indexes:

Not included

Website:

http://tcbiopharm.com

Description:

TC Biopharm (Holdings) is a biotechnology company focused on developing innovative cell therapies for cancer treatment. They aim to harness the power of the immune system to target and destroy cancer cells, improving patient outcomes and advancing the field of personalized medicine.

Key Details

Price

$1.92

Market Cap

$984.96 K(Small cap)

Last Dividend

$0.25

TTM Dividend Yield

13.02%

Annual Revenue

-

Annual EPS

-$3822.56(+49.50% YoY)

PE Ratio

-

Annual ROE

-214.87%

Annual Debt To Equity

0.67

Beta

-1.03

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Jan 2, 2025
Splits

Next split:

N/A

Recent split:

Feb 10, 2025

Analyst ratings

Recent major analysts updates

Dec 6, 24 HC Wainwright & Co.
Buy
Apr 27, 23 HC Wainwright & Co.
Buy
Jan 26, 23 HC Wainwright & Co.
Buy
Mar 28, 22 EF Hutton
Buy

Screeners with TCBP included

Growing Shares Outstanding
UK stocks
Biggest stock losers today
Stocks below SMA 200
Healthcare sector
All stocks
High yield dividend stocks
Stocks with all time high dividends
Biotechnology industry
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.92
TCBP price is $1.92

Price All-time High

$4240000.00
TCBP price is currently -100.00% below its historical high of $4240000.00

Price Analysts Target

-
TCBP price consensus analysts' forecast is unknown

Price Today Change

-9%
TCBP price is down -9% today

Price YTD Change

-85.12%
TCBP price is down -85.12% since January 1st

Price 3-Year Change

-100%
TCBP price is down -100% over the past 3 years

Market cap

Market Cap

$984.96 K
TCBP market capitalization is $984.96 thousand

Market Cap 3-Year Change

-99.76%
TCBP market capitalization is down -99.76% over the past 3 years

Market Cap All-time High

$848.00 M
TCBP market capitalization is currently -99.88% below its historical high of $848.00 million

Market Cap Sector Rank

3.46%
TCBP market capitalization is higher than 3.46% of companies in Healthcare sector

Technical

Beta

-1.03
TCBP beta is -1.03

200-day SMA

$86.13
TCBP price is currently -97.77% below its 200-day simple moving average

14-day RSI

26.19
TCBP 14-day relative strength index is 26.19

30-day Relative Volume

0.30
TCBP 30-day relative volume is 0.30

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.25
TCBP last dividend was $0.25 per share, with an ex-dividend date of January 2, 2025

Next Dividend

-
TCBP next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

-
TCBP annual dividend per share value is unknown

Annual Dividend Per Share Sector Rank

-
TCBP annual dividend per share is unknown

Annual Dividend Per Share 1-Year Change

-
TCBP annual dividend per share 1-year change is unknown

Annual Dividend Per Share 3-Year Change

-
TCBP annual dividend per share 3-year change is unknown

Dividend yield

Annual Dividend Yield

-
TCBP annual dividend yield value is unknown

Annual Dividend Yield Sector Rank

-
TCBP annual dividend yield is unknown

Other

Annual Payout Ratio

-
TCBP annual payout ratio value is unknown

Annual Dividends Paid

-
TCBP annual dividends paid value is unknown

Annual FCF

-$13.38 M
TCBP annual free cash flow is -$13.38 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
TCBP annual revenue value is unknown

Annual Revenue Analysts Estimate

-
TCBP annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
TCBP annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
TCBP annual revenue is unknown

Profit

Annual Gross Profit

-
TCBP annual gross profit value is unknown

Annual Gross Margin

-
TCBP annual gross profit margin value is unknown

Annual Operating Profit

-$17.72 M
TCBP annual operating income is -$17.72 million

Annual Operating Margin

-
TCBP annual operating profit margin value is unknown

Annual Net Income

-$7.35 M
TCBP annual net profit is -$7.35 million

Annual Net Margin

-
TCBP annual net profit margin value is unknown

EPS

Annual EPS

-$3822.56
TCBP annual earnings per share is -$3822.56

Annual EPS Analysts Estimate

-
TCBP annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+49.5%
TCBP annual earnings per share is up +49.5% year-on-year

Annual EPS Sector Rank

0.5%
TCBP annual earnings per share is higher than 0.5% of companies in Healthcare sector

ROA & ROE

Annual ROA

-64.60%
TCBP annual return on assets is -64.60%

Annual ROE

-214.87%
TCBP annual return on equity is -214.87%

EBIT & EBITDA

Annual EBIT

-$8.60 M
TCBP annual earnings before interest & taxes is -$8.60 million

Annual EBITDA

-$7.81 M
TCBP annual EBITDA is -$7.81 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
TCBP price to earnings ratio value is unknown

PE Ratio Sector Rank

-
TCBP price to earnings ratio is unknown

PB Ratio

PB Ratio

0.39
TCBP price to book ratio is 0.39

PB Ratio Sector Rank

25.25%
TCBP price to book ratio is higher than 25.25% of companies in Healthcare sector

PS Ratio

PS Ratio

-
TCBP price to sales ratio value is unknown

PS Ratio Sector Rank

-
TCBP price to sales ratio is unknown

Enterprise value

Enterprise Value

$1.81 M
TCBP enterprise value is $1.81 million

Enterprise Value Sector Rank

15%
TCBP enterprise value is higher than 15% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.27
TCBP EV/EBITDA is -0.27

EV/EBITDA Sector Rank

58.41%
TCBP EV/EBITDA is higher than 58.41% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.20
TCBP annual current ratio is 1.20

Annual Quick Ratio

-
TCBP annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.67
TCBP annual debt to equity ratio is 0.67

Annual Interest Coverage Ratio

-83.27
TCBP annual interest coverage ratio is -83.27

Risk & Stability

Piotroski F-Score

-
TCBP piotroski f-score value is unknown

Altman Z-Score

-
TCBP altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$11.38 M
TCBP annual total assets is $11.38 million

Annual Non Current Assets

$4.12 M
TCBP annual long term assets is $4.12 million

Annual Current Assets

$7.26 M
TCBP annual total current assets is $7.26 million

Annual Cash & Cash Equivalents

$3.14 M
TCBP annual cash & cash equivalents is $3.14 million

Equity

Annual Book Value

$3.42 M
TCBP annual book value is $3.42 million

Annual Working Capital

$1.21 M
TCBP annual working capital is $1.21 million

Liabilities

Annual Total Liabilities

$7.96 M
TCBP annual total liabilities is $7.96 million

Annual Total Long Term Liabilities

$1.91 M
TCBP annual total long term liabilities is $1.91 million

Annual Current Liabilities

$6.05 M
TCBP annual total current liabilities is $6.05 million

Annual Accounts Payable

$2.35 M
TCBP annual accounts payable is $2.35 million

Debt

Annual Total Debt

$2.29 M
TCBP annual total debt is $2.29 million

Annual Total Debt 1-Year Change

-31.76%
TCBP annual total debt is down -31.76% year-on-year

Annual Long Term Debt

$1.91 M
TCBP annual long term debt is $1.91 million

Annual Short Term Debt

$389.00 K
TCBP annual short term debt is $389.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$17.72 M
TCBP annual total expenses is $17.72 million

Annual Operating Expenses

$17.72 M
TCBP annual total operating expenses is $17.72 million

Annual Cost Of Goods Sold

-
TCBP annual cost of goods sold value is unknown

Annual SGA

$8.05 M
TCBP annual SGA is $8.05 million

Annual D&A

$787.70 K
TCBP annual depreciation & amortization is $787.70 thousand

Annual Interest Expense

$103.30 K
TCBP annual interest expense is $103.30 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$13.12 M
TCBP annual cash flow from operations is -$13.12 million

Annual CFO 1-Year Change

+30.71%
TCBP annual cash flow from operations is up +30.71% year-on-year

Annual CFI

-$259.80 K
TCBP annual cash flow from investing activities is -$259.80 thousand

Annual CFI 1-Year Change

+32.36%
TCBP annual cash flow from investing activities is up +32.36% year-on-year

Annual CFF

$10.60 M
TCBP annual cash flow from financing activities is $10.60 million

Annual CFF 1-Year Change

-54.1%
TCBP annual cash flow from financing activities is down -54.1% year-on-year

Free CashFlow

Annual FCF

-$13.38 M
TCBP annual free cash flow is -$13.38 million

Annual FCF 1-Year Change

+30.99%
TCBP annual free cash flow is up +30.99% year-on-year

CAPEX

Annual CAPEX

-
TCBP annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
TCBP annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

NVOS logo
Novo Integrated Sciences (NVOS)
TNF Pharmaceuticals (TNFA)
BIOC logo
Biocept (BIOC)
NAOV logo
NanoVibronix (NAOV)
BIOR logo
Biora Therapeutics (BIOR)
PTPI logo
Petros Pharmaceuticals (PTPI)
DYNT logo
Dynatronics (DYNT)
HEPA logo
Hepion Pharmaceuticals (HEPA)
CWBR logo
CohBar (CWBR)

FAQ

  • What is the ticker symbol for TC Biopharm (Holdings)?
  • Does TC Biopharm (Holdings) pay dividends?
  • What sector is TC Biopharm (Holdings) in?
  • What industry is TC Biopharm (Holdings) in?
  • What country is TC Biopharm (Holdings) based in?
  • When did TC Biopharm (Holdings) go public?
  • Is TC Biopharm (Holdings) in the S&P 500?
  • Is TC Biopharm (Holdings) in the NASDAQ 100?
  • Is TC Biopharm (Holdings) in the Dow Jones?
  • When does TC Biopharm (Holdings) report earnings?

What is the ticker symbol for TC Biopharm (Holdings)?

The ticker symbol for TC Biopharm (Holdings) is NASDAQ:TCBP

Does TC Biopharm (Holdings) pay dividends?

Yes, TC Biopharm (Holdings) pays dividends. The last payment was $0.25, with an ex-dividend date on January 2, 2025

What sector is TC Biopharm (Holdings) in?

TC Biopharm (Holdings) is in the Healthcare sector

What industry is TC Biopharm (Holdings) in?

TC Biopharm (Holdings) is in the Biotechnology industry

What country is TC Biopharm (Holdings) based in?

TC Biopharm (Holdings) is headquartered in United Kingdom

When did TC Biopharm (Holdings) go public?

TC Biopharm (Holdings)'s initial public offering (IPO) was on February 11, 2022

Is TC Biopharm (Holdings) in the S&P 500?

No, TC Biopharm (Holdings) is not included in the S&P 500 index

Is TC Biopharm (Holdings) in the NASDAQ 100?

No, TC Biopharm (Holdings) is not included in the NASDAQ 100 index

Is TC Biopharm (Holdings) in the Dow Jones?

No, TC Biopharm (Holdings) is not included in the Dow Jones index

When does TC Biopharm (Holdings) report earnings?

The date for TC Biopharm (Holdings)'s next earnings report has not been announced yet